Pardes Biosciences, Inc

Frazier Healthcare Partners

edited on 7 Sep, 2023

Edits made to:

Infobox (+1/-1 properties)

Infobox

Number of Employees (Ranges)

20 – 49

Number of Employees (Ranges)

10 – 19

Edits on 17 Jul, 2023

Amy Tomlinson Gayle

edited on 17 Jul, 2023

Edits made to:

Description (+123/-44 characters)

Pardes Biosciences, Inc

Dedicated to solving pandemic-sized problems

Pardes is a clinical-stage biopharmaceutical company created to help solve pandemic-related issues, starting with COVID-19.

"prospector:2975:3539889"

Amy Sar

edited on 17 Jul, 2023

Edits made to:

Infobox (+1 properties)

Infobox

Industry

Life science

Edits on 15 Jul, 2023

"prospector:2975:3539889"

Amy Sar

edited on 15 Jul, 2023

Edits made to:

Infobox (+1 properties)

Description (+44 characters)

Pardes Biosciences, Inc

Dedicated to solving pandemic-sized problems

Infobox

Investors

Edits on 16 Mar, 2023

"prospector:2473:2559477"

edited on 16 Mar, 2023

Edits made to:

Infobox (+1 properties)

Infobox

Industry

Biotechnology

"prospector:2472:2544205"

edited on 16 Mar, 2023

Edits made to:

Infobox (+1 properties)

Infobox

Industry

Biology

Edits on 22 Feb, 2023

"prospector:2317:2472803"

https://www.facebook.com/pardesbio

edited on 22 Feb, 2023

Edits made to:

Infobox (+1 properties)

Infobox

Industry

Technology

Edits on 21 Aug, 2022

Andrey Duzenko

edited on 21 Aug, 2022

Edits made to:

Infobox (+4 properties)

Infobox

Exchange

CEO

CFO

Facebook URL

Stock Symbol

PRDS0

Edits on 11 Jun, 2022

"Entity importer update"

https://www.crunchbase.com/organization/pardes-biosciences

edited on 11 Jun, 2022

Edits made to:

Infobox (+1 properties)

Infobox

Is a

Organization

Edits on 4 Jun, 2022

N Ni

edited on 4 Jun, 2022

Edits made to:

Infobox (+9 properties)

Infobox

Company Operating Status

Active

Crunchbase

Industry

Speciality chemicals

LinkedIn URL

https://www.linkedin.com/company/pardesbio/

Number of Employees (ranges)

20 – 49

Pitchbook URL

https://pitchbook.com/profiles/company/459381-97

Exchange

Nasdaq

Ticker symbol

PRDS0

Edits on 8 Apr, 2022

"Patent autocalculation"

edited on 8 Apr, 2022

Edits made to:

Infobox (+1 properties)

Infobox

Patents assigned (count)

Edits on 14 Dec, 2021

"Remove inverse infobox"

edited on 14 Dec, 2021

Edits made to:

Infobox (-2 properties)

Infobox

Patents

US Patent 11124497 Inhibitors of cysteine proteases and methods of use thereof

US Patent 11174231 Inhibitors of cysteine proteases and methods of use thereof

Edits on 18 Nov, 2021

edited on 18 Nov, 2021

Edits made to:

Infobox (+1 properties)

Infobox

Patents

US Patent 11174231 Inhibitors of cysteine proteases and methods of use thereof

Edits on 22 Sep, 2021

edited on 22 Sep, 2021

Edits made to:

Infobox (+1 properties)

Infobox

Patents

US Patent 11124497 Inhibitors of cysteine proteases and methods of use thereof

Edits on 23 Feb, 2021

"Setting founded date to the company's date of incorporation."

https://www.pardesbio.com/

edited on 23 Feb, 2021

Edits made to:

Infobox (+1 properties)

Infobox

Founded date

2020

Edits on 6 Feb, 2021

"Approved suggestion from source: https://www.pardesbio.com/"

Henry Ogolla

approved a suggestion from Golden's AI on 6 Feb, 2021

Edits made to:

Pardes Biosciences, Inc

Pardes is a clinical-stage biopharmaceutical company created to help solve pandemic-related issues, starting with COVID-19.

Edits on 5 Feb, 2021

"Research engine edit"

Jed Christiansen

edited on 5 Feb, 2021

Edits made to:

Infobox (+1 properties)

Infobox

Website

Edits on 3 Feb, 2021

"Funding autocalculation"

edited on 3 Feb, 2021

Edits made to:

Infobox (+2 properties)

Infobox

Latest funding round date

February 2021

Total funding amount (USD)

51,614,997

edited on 3 Feb, 2021

Edits made to:

Infobox (+1 properties)

Infobox

Funding rounds